1-1 of 1
Authors: Danielle Awad
Sort by
Journal Article
Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment
Get access
Dawn L. Hershman and others
The Journal of Clinical Endocrinology & Metabolism, Volume 95, Issue 2, 1 February 2010, Pages 559–566, https://doi.org/10.1210/jc.2009-1366
Published: 01 February 2010
Advertisement
Advertisement